Chronic obstructive pulmonary disease: effects beyond the lungs

scientific article

Chronic obstructive pulmonary disease: effects beyond the lungs is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1371/JOURNAL.PMED.1000220
P932PMC publication ID2838746
P698PubMed publication ID20305715
P5875ResearchGate publication ID42372671

P2093author name stringPeter J Barnes
P2860cites workThe metabolic syndrome in patients with chronic bronchitis and COPD: frequency and associated consequences for systemic inflammation and physical inactivity.Q53951321
Arterial Stiffness and Osteoporosis in Chronic Obstructive Pulmonary DiseaseQ58057647
Chronic Obstructive Pulmonary Disease Is Associated with Lung Cancer Mortality in a Prospective Study of Never SmokersQ58260316
From COPD to chronic systemic inflammatory syndrome?Q58877168
Cardiovascular magnetic resonance imaging to identify left-sided chronic heart failure in stable patients with chronic obstructive pulmonary diseaseQ81901203
Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseQ29618681
Circulating surfactant protein D as a potential lung-specific biomarker of health outcomes in COPD: a pilot studyQ33301961
The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trialQ34394365
COPD prevalence is increased in lung cancer, independent of age, sex and smoking historyQ34604212
Cognitive decline among patients with chronic obstructive pulmonary diseaseQ34979736
Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysisQ35536791
Osteoporosis in chronic obstructive pulmonary disease patientsQ37095795
COPD as a disease of accelerated lung agingQ37366212
Systemic manifestations and comorbidities of COPD.Q37465879
Airflow obstruction and metabolic syndrome: the Guangzhou Biobank Cohort Study.Q39965893
Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary diseaseQ43281145
Vascular dysfunction in chronic obstructive pulmonary disease.Q45960606
Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD.Q46562371
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectchronic obstructive pulmonary diseaseQ199804
P304page(s)e1000220
P577publication date2010-03-16
P1433published inPLOS MEDICINEQ1686921
P1476titleChronic obstructive pulmonary disease: effects beyond the lungs.
P478volume7

Reverse relations

cites work (P2860)
Q36817922A comparison of cognitive functions in non-hypoxemic chronic obstructive pulmonary disease (COPD) patients and age-matched healthy volunteers using mini-mental state examination questionnaire and event-related potential, P300 analysis
Q28394423Air Pollution and Lung Function Loss: The Importance of Metabolic Syndrome
Q47728819An overview of the current management of chronic obstructive pulmonary disease: can we go beyond the GOLD recommendations?
Q90705495Anti-Inflammatory Effects of Licania macrocarpa Cuatrec Methanol Extract Target Src- and TAK1-Mediated Pathways
Q36137286Assessment of cognitive impairment in long-term oxygen therapy-dependent COPD patients.
Q36345889Association Between Emphysema Score, Six-Minute Walk and Cardiopulmonary Exercise Tests in COPD.
Q23918414Biomarkers of World Trade Center particulate matter exposure: physiology of distal airway and blood biomarkers that predict FEV1 decline
Q26786812COPD and its comorbidities: Impact, measurement and mechanisms
Q60301064COPD patients hospitalized with exacerbations have greater cognitive impairment than patients hospitalized with decompensated heart failure
Q89219136Chronic obstructive pulmonary disease
Q55381292Chronic obstructive pulmonary disease and acute myocardial infarction: effects on presentation, management, and outcomes.
Q34228984Chronic obstructive pulmonary disease and the metabolic syndrome: Consequences of a dual threat
Q36308003Chronic obstructive pulmonary disease as a cardiovascular risk factor. Results of a case-control study (CONSISTE study).
Q50698868Diabetes mellitus among outpatients with COPD attending a university hospital.
Q58694600Difference in systemic inflammation and predictors of acute exacerbation between smoking-associated COPD and tuberculosis-associated COPD
Q46738415Differences in clinical characteristics, management and short-term outcome between acute heart failure patients chronic obstructive pulmonary disease and those without this co-morbidity
Q64095387Disrupted resting-state spontaneous neural activity in stable COPD
Q51760032Double deletion of tetraspanins CD9 and CD81 in mice leads to a syndrome resembling accelerated aging.
Q39440580Effect of Hypoxic Injury in Mood Disorder
Q88536449Evaluation for airway obstruction in adult patients with stable ischemic heart disease
Q36929346Evaluation of C-Reactive Protein in Patients with Chronic Obstructive Pulmonary Disease
Q28383778Gene promoter methylation is associated with lung function in the elderly: the Normative Aging Study
Q28730169Grey and white matter abnormalities in chronic obstructive pulmonary disease: a case-control study
Q34390635Heart failure and chronic obstructive pulmonary disease: Two for tea or tea for two?
Q36677305High-sensitivity cardiac troponin T levels are increased in stable COPD.
Q86984320IL-21 is increased in peripheral blood of emphysema mice and promotes Th1/Tc1 cell generation in vitro
Q34126289Identification of Novel Therapeutic Targets in COPD.
Q34126693Immunological Features of Chronic Obstructive Pulmonary Disease (COPD) Induced by Indoor Pollution and Cigarette Smoke
Q48541057Impact of pharmaceutical care on health outcomes in patients with COPD.
Q33592661Increased risk and related factors of depression among patients with COPD: a population-based cohort study.
Q90636017Increased von Willebrand Factor Processing in COPD, Reflecting Lung Epithelium Damage, Is Associated with Emphysema, Exacerbations and Elevated Mortality Risk
Q23909997Inflammatory biomarkers predict airflow obstruction after exposure to World Trade Center dust
Q37964807Link between chronic obstructive pulmonary disease and coronary artery disease: implication for clinical practice
Q35204219Lung disease as a determinant of cognitive decline and dementia
Q27005858Managing comorbidities in COPD
Q62731134Metabolic Syndrome and Air Pollution: A Narrative Review of Their Cardiopulmonary Effects
Q92068171Metabolic Syndrome in Early Chronic Obstructive Pulmonary Disease: Gender Differences and Impact on Exacerbation and Medical Costs
Q37102124Metabolic syndrome and chronic obstructive pulmonary disease
Q23910631Metabolic syndrome biomarkers predict lung function impairment: a nested case-control study
Q33554524Metabolic syndrome in patients with chronic obstructive pulmonary disease: frequency and relationship with systemic inflammation
Q38821943MicroRNA expression profiling defines the impact of electronic cigarettes on human airway epithelial cells.
Q62111191Myocardial Infarction and Ischemic Stroke after Exacerbations of Chronic Obstructive Pulmonary Disease
Q21146673Network medicine analysis of COPD multimorbidities
Q35009154Neural mechanisms underlying breathing complexity
Q38131512New anti-inflammatory targets for chronic obstructive pulmonary disease.
Q64118155New frontiers in the treatment of comorbid cardiovascular disease in chronic obstructive pulmonary disease
Q39020385Pathogenesis of COPD and Asthma.
Q64067266Prior cigarette smoke exposure does not affect acute post-stroke outcomes in mice
Q64913353Reduced Lung Function in Midlife and Cognitive Impairment in the Elderly.
Q40927157Reduced cortical thickness, surface area in patients with chronic obstructive pulmonary disease: a surface-based morphometry and neuropsychological study
Q48420302Reduced regional gray matter volume in patients with chronic obstructive pulmonary disease: a voxel-based morphometry study
Q41665936Relationship between pulmonary function and elevated glycated hemoglobin levels in health checkups: A cross-sectional observational study in Japanese participants
Q53305583Roflumilast inhibits leukocyte-platelet interactions and prevents the prothrombotic functions of polymorphonuclear leukocytes and monocytes.
Q38306695Safety of inhaled corticosteroids for treating chronic obstructive pulmonary disease.
Q35667313Self Reported Childhood Difficulties, Adult Multimorbidity and Allostatic Load. A Cross-Sectional Analysis of the Norwegian HUNT Study
Q37006598The Prevalence of Diabetes Mellitus in COPD Patients with Severe and Very Severe Stage of the Disease
Q60921746The Role of Omega-3 Fatty Acids in the Setting of Coronary Artery Disease and COPD: A Review
Q33719462The effects of sleep hypoxia on coagulant factors and hepatic inflammation in emphysematous rats
Q33832184Uncovering Metabolic Syndrome among Chronic Obstructive Pulmonary Disease Patients in a Tertiary Care Hospital, India
Q37896652Update in chronic obstructive pulmonary disease: role of antioxidant and metabolizing gene polymorphisms
Q60050074Visual rating assessment of cerebral atrophy and its relationship with cognitive function in chronic obstructive pulmonary disease
Q58840477What the Journal Would Like to Publish on Chronic Obstructive Pulmonary Disease
Q36265683Which patients with advanced respiratory disease die in hospital? A 14-year population-based study of trends and associated factors
Q33810474White matter lesions characterise brain involvement in moderate to severe chronic obstructive pulmonary disease, but cerebral atrophy does not
Q84766067[Pulmonary diseases in the elderly]
Q85648640[Stress and optimal ageing]

Search more.